TY - JOUR T1 - The association of lung cancer with pulmonary fibrosis JF - ERJ Open Research JO - erjor DO - 10.1183/23120541.00505-2021 SP - 00505-2021 AU - Niranjan Jeganathan AU - Derrick Cleland AU - Matheni Sathananthan Y1 - 2021/01/01 UR - http://openres.ersjournals.com/content/early/2021/11/11/23120541.00505-2021.abstract N2 - Idiopathic pulmonary fibrosis (IPF) shares several pathogenetic similarities to other fibrotic lung diseases. Patients with IPF are considered to have a higher risk of concomitant lung cancer (LC) as a result of similar risk factors which include older age, smoking, and male sex. Patients with IPF have a poor prognosis with a median survival time ranging from 2–5 years [1]. It is not yet known if LC is a significant contributor to deaths in those with IPF. To address this question, we evaluated the association between LC and IPF compared to all non-IPF decedents in the U.S. from 2004–2018.FootnotesThis manuscript has recently been accepted for publication in the ERJ Open Research. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJOR online. Please open or download the PDF to view this article.Conflict of interest: Dr. Jeganathan has nothing to disclose.Conflict of interest: Dr. Cleland has nothing to disclose.Conflict of interest: Dr. Sathananthan has nothing to disclose. ER -